Companies: 10,638     total market cap: โ‚น12133.559 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Novavax
NVAX
#5817
Rank
โ‚น97.24 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
โ‚น598.46
Share price
-1.77%
Change (1 day)
-22.23%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

Novavax (NVAX) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚น106.02 Billion

According to Novavax's latest financial reports the company's total assets are โ‚น106.02 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Novavax - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚น133.86 B-10.54%
2023-12-31โ‚น149.63 B-19.94%
2022-12-31โ‚น186.90 B-2.55%
2021-12-31โ‚น191.79 B65.72%
2020-12-31โ‚น115.73 B838.35%
2019-12-31โ‚น12.33 B-15.19%
2018-12-31โ‚น14.54 B-24.71%
2017-12-31โ‚น19.31 B-27.92%
2016-12-31โ‚น26.79 B4.45%
2015-12-31โ‚น25.65 B46.66%
2014-12-31โ‚น17.49 B20.42%
2013-12-31โ‚น14.52 B159.22%
2012-12-31โ‚น5.60 B59.11%
2011-12-31โ‚น3.52 B5.01%
2010-12-31โ‚น3.35 B-15.57%
2009-12-31โ‚น3.97 B7.85%
2008-12-31โ‚น3.68 B2.8%
2007-12-31โ‚น3.58 B-33.63%
2006-12-31โ‚น5.39 B42.16%
2005-12-31โ‚น3.79 B12.42%
2004-12-31โ‚น3.37 B-11.85%
2003-12-31โ‚น3.83 B38.95%
2002-12-31โ‚น2.75 B-14.85%
2001-12-31โ‚น3.23 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Agenus
AGEN
โ‚น21.01 B-80.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น313.91 B 196.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น131.28 B 23.83%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น40.11 B-62.16%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น10.284 T 9,600.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚น18.756 T 17,590.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น9.640 T 8,993.14%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
โ‚น0.79 B-99.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น7.409 T 6,888.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
โ‚น58.26 B-45.04%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com